A final hybrid town hall was hosted on May 2, 2024, to present a design preview of the new University of Maryland School of Social Work building. The project is expected to break ground in October 2024.Learn more at https://www.umaryland.edu/designandconstruction/capital-projects/projects/school-of-social-work-building-project/

Recognize the humanity in people, and don't define them by their disabilities.Sydnee Chavis, DMD, MS, clinical assistant professor in the Department of Oral and Maxillofacial Surgery in the University of Maryland School of Dentistry, shares a story about growing up with her older sister, Brandy, who has cerebral palsy and developmental disabilities, and how she didn’t perceive her as different until the family was out to dinner one night.

Experts need integrity and benevolence above all else to gain public trust.Andrew Coop, PhD, MA, professor in the Department of Pharmaceutical Sciences and associate dean for Graduate Programs in the University of Maryland School of Pharmacy, shared those words during the third annual Faculty Convocation at the University of Maryland, Baltimore.Dr. Coop has been a faculty member at the University of Maryland School of Pharmacy since 1999, serving as chair of the Department of Pharmaceutical Sciences (PSC) from 2007 to 2015. In addition to his current role as UMSOP’s associate dean for graduate programs, he previously served as the school’s associate dean for academic affairs from 2016 to 2024 and as PSC’s vice chair of academic affairs from 2006 to 2007.Dr. Coop has received funding from the National Institutes of Health’s National Institute on Drug Abuse for his research on opioids, stimulants, and depressants, all of which were interdisciplinary projects concerned with the design and development of novel tools to allow pharmacological study of the biological systems involved in the abuse of these drugs.

With the power of augmented reality, University of Maryland School of Graduate Studies physician assistant students are seeing real-time anatomy and symptoms up close, and take control of their @UMBaltimore medical education like never before.This is the HaloCamera, which is a volumetric capture studio at @UofMaryland that uses 300 cameras and AI-powered data to create lifelike 3D simulations, helping medical students and professionals experience patient care in an entirely new way. #MPowerMD #MedicalEducation #Innovation #AR #VR

Medical educators at the University of Maryland, Baltimore led by Dr. Cheri Hendrix and computer scientists at the University of Maryland, College Park led by Amitabh Varshney collaborate to teach physician assistants with the help of an immersive virtual reality tool called HoloCamera.The HaloCamera is a volumetric capture studio, which is the same technology used in virtual reality and augmented reality games and providing character modeling in movies. This revolutionary technology uses 300 cameras and AI-powered data to create lifelike 3D simulations, helping medical students and professionals experience patient care in an entirely new way. Watch as virtual patients come to life, allowing physician assistant students at the University of Maryland School of Graduate Studies, located in Baltimore, to see real-time anatomy and symptoms up close, and take control of their medical education like never before.#Halocamera #MedicalTraining #3DTech #AIinMedicine

How do researchers and scholars build public trust? It's all about integrity and benevolence.Andrew Coop, PhD, MA, professor in the Department of Pharmaceutical Sciences and associate dean for Graduate Programs in the University of Maryland School of Pharmacy, shared those words during the third annual Faculty Convocation at the University of Maryland, Baltimore.Dr. Coop has been a faculty member at the University of Maryland School of Pharmacy since 1999, serving as chair of the Department of Pharmaceutical Sciences (PSC) from 2007 to 2015. In addition to his current role as UMSOP’s associate dean for graduate programs, he previously served as the school’s associate dean for academic affairs from 2016 to 2024 and as PSC’s vice chair of academic affairs from 2006 to 2007. Coop has received funding from the National Institutes of Health’s National Institute on Drug Abuse for his research on opioids, stimulants, and depressants, all of which were interdisciplinary projects concerned with the design and development of novel tools to allow pharmacological study of the biological systems involved in the abuse of these drugs